Maternal Mental Health Trial

Recruiting Phase 1 Phase 2 Interventional Study
Major Depressive Disorder Postpartum Depression
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Female
Trial phase
Phase 1/2
Study type
Interventional
Purpose
Prevention
Participants needed
220 (estimated)
Sponsor
Vibe G Frøkjær, MD, PhD · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Perinatal depression affects 10-15% of women postpartum and has a recurrence rate of 40%. Women who develop perinatal depression might be particularly susceptible to the rapid and large changes in sex steroid hormones, particularly estradiol, across pregnancy to postpartum. This trial aims 1) to evaluate the preventive effect of transdermal estradiol treatment in the immediate postpartum on depres…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Singleton pregnant * Prior history of perinatal depression * Age between 18 and 45 years Exclusion Criteria: * Moderate to severe depression with onset during pregnancy * Severe psychiatric disorders (e.g. disorders with psychotic symptoms, schizophrenia, bipolar disorders, …
Contacts

Vibe Gedsø Frøkjær, MD, PhD

+45 35456714

vibe@nru.dk

CONTACT

Stinne Høgh, RM, MSc

+45 22973556

stinne.hoegh@regionh.dk

CONTACT